Winston Pharmaceuticals, Inc. (WPHM)

[atout]

Phillip Frost

B.A, French literature, University of Pennsylvania, 1957
M.D. Albert Einstein College of Medicine, 1961.



Dr. Frost is nationally recognized for his business acumen and creative enterprise. He invented a disposable biopsy device in 1971.

Dr. Frost took over Key Pharmaceuticals in 1972 and sold it to Schering Plough in 1986. He was Chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida from 1972 to 1986. He started Ivax in 1987 which was bought by Teva Industrial Pharmaceuticals for $7.4B in 2006. Dr. Phillip Frost was then named Vice Chairman of the Board of Teva

Dr. Frost was named Chairman of the Board of Ladenburg Thalman & Co., Inc., an American Stock Exchange-listed investment banking and securities brokerage firm, in July 2006 and has been a director of Ladenburg Thalman since March 2004.

He is on the Board of Regents of the Smithsonian Institution, a member of the Board of Trustees of the University of Miami, a Trustee of the Scripps Research Institute, and is a Vice Chairman of the Board of Governors of the American Stock Exchange. Dr. Frost is also a director of Continucare Corporation, an American Stock Exchange-listed provider of outpatient healthcare and home healthcare services, Northrop Grumman Corp., a New York Stock Exchange-listed global defense and aerospace company, Castle Brands, Inc., an American Stock Exchange-listed developer and marketer of liquor, and Cellular Technical Services, Inc., a provider of products and services for the telecommunications industry.

Chairman and Chief Executive of Opko Corporation (3/27/2007) see #board-6654 (merger into Exegenics).


Phillip Frost's NEW VISION:
http://www.ladenburg.com/uploads/NewVisionArticleMH11506.pdf